Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherBasic Science Investigations

3-O-Methyl-6-18F-Fluoro-l-Dopa, a New Tumor Imaging Agent: Investigation of Transport Mechanism In Vitro

Ralf Bergmann, Jens Pietzsch, Frank Fuechtner, Beate Pawelke, Bettina Beuthien-Baumann, Bernd Johannsen and Joerg Kotzerke
Journal of Nuclear Medicine December 2004, 45 (12) 2116-2122;
Ralf Bergmann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jens Pietzsch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Fuechtner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beate Pawelke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bettina Beuthien-Baumann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernd Johannsen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joerg Kotzerke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Reaction scheme of synthesis of OMFD (9).

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Representative curves showing time course of OMFD uptake in HT-29 cells without (control) and with various concentrations of BCH in incubation medium (A) and OMFD uptake velocity (k) in HT-29 cells in presence of various concentrations of BCH (B). Data are mean ± SEM (n = 4).

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Influence of specific amino acid transporter inhibitors, sodium, and choline (without sodium) on OMFD uptake in HT-29, FaDu, and RBE4 cells. Data are mean ± SEM (n = 4). **P < 0.01; ***P < 0.001 (Student t test, SPSS software package).

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Kinetics of OMFD release in HT-29 cells in presence and absence of BCH at 37°C after preloading of OMFD. Data are mean ± SEM (n = 4).

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    Concentration-dependent OMFD uptake in adenocarcinoma cells (HT-29) (A) and squamous carcinoma cells (FaDu) (B). OMFD uptake was measured with varying concentrations of unlabeled 19F-OMFD between 0 and 150 μmol/L. Data are mean ± SEM (n = 4). (C and D) Corresponding Eadie–Hofstee plots. v = initial velocity of OMFD uptake; S = substrate concentration.

  • FIGURE 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6.

    Comparison of OMFD and 3H-l-leucine uptake in adenocarcinoma cells (HT-29) in absence and presence of various BCH concentrations after incubation at 1, 2, 3, 5, 7, and 10 min. Data are mean ± SEM (n = 4).

  • FIGURE 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 7.

    (A) Influence of incubation temperature on OMFD uptake in adenocarcinoma (HT-29) without (control) and with 6 mmol BCH per liter. (B) Influence of various concentrations of sodium azide on OMFD uptake in adenocarcinoma (HT-29) and squamous carcinoma (FaDu) cells. Data are mean ± SEM (n = 4).

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 45 (12)
Journal of Nuclear Medicine
Vol. 45, Issue 12
December 1, 2004
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
3-O-Methyl-6-18F-Fluoro-l-Dopa, a New Tumor Imaging Agent: Investigation of Transport Mechanism In Vitro
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
3-O-Methyl-6-18F-Fluoro-l-Dopa, a New Tumor Imaging Agent: Investigation of Transport Mechanism In Vitro
Ralf Bergmann, Jens Pietzsch, Frank Fuechtner, Beate Pawelke, Bettina Beuthien-Baumann, Bernd Johannsen, Joerg Kotzerke
Journal of Nuclear Medicine Dec 2004, 45 (12) 2116-2122;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
3-O-Methyl-6-18F-Fluoro-l-Dopa, a New Tumor Imaging Agent: Investigation of Transport Mechanism In Vitro
Ralf Bergmann, Jens Pietzsch, Frank Fuechtner, Beate Pawelke, Bettina Beuthien-Baumann, Bernd Johannsen, Joerg Kotzerke
Journal of Nuclear Medicine Dec 2004, 45 (12) 2116-2122;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • THIS MONTH IN JNM
  • PubMed
  • Google Scholar

Cited By...

  • False-positive findings on 6-[18F]fluor-L-3,4-dihydroxyphenylalanine PET (18F-FDOPA-PET) performed for imaging of neuroendocrine tumors
  • Impact of 3,4-Dihydroxy-6-18F-Fluoro-L-Phenylalanine PET/CT on Managing Patients with Brain Tumors: The Referring Physician's Perspective
  • L-Type Amino Acid Transporters LAT1 and LAT4 in Cancer: Uptake of 3-O-Methyl-6- 18F-Fluoro-L-Dopa in Human Adenocarcinoma and Squamous Cell Carcinoma In Vitro and In Vivo
  • 18F-FDOPA Kinetics in Brain Tumors
  • Clinical Applications of PET in Brain Tumors
  • 18F-FDOPA PET Imaging of Brain Tumors: Comparison Study with 18F-FDG PET and Evaluation of Diagnostic Accuracy
  • Google Scholar

More in this TOC Section

  • 11C-Methionine PET of Myocardial Inflammation in a Rat Model of Experimental Autoimmune Myocarditis
  • Counting Rate Characteristics and Image Distortion in Preclinical PET Imaging During Radiopharmaceutical Therapy
  • Design and Fabrication of Kidney Phantoms for Internal Radiation Dosimetry Using 3D Printing Technology
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire